Faes Farma Balance Sheet Health
Financial Health criteria checks 5/6
Faes Farma has a total shareholder equity of €686.0M and total debt of €47.4M, which brings its debt-to-equity ratio to 6.9%. Its total assets and total liabilities are €837.5M and €151.5M respectively. Faes Farma's EBIT is €109.7M making its interest coverage ratio 211.4. It has cash and short-term investments of €69.8M.
Key information
6.9%
Debt to equity ratio
€47.44m
Debt
| Interest coverage ratio | 211.4x |
| Cash | €69.84m |
| Equity | €686.01m |
| Total liabilities | €151.52m |
| Total assets | €837.53m |
Recent financial health updates
Does Faes Farma (BME:FAE) Have A Healthy Balance Sheet?
Nov 24
Here's Why Faes Farma (BME:FAE) Can Manage Its Debt Responsibly
May 03Is Faes Farma (BME:FAE) A Risky Investment?
Aug 03Is Faes Farma (BME:FAE) Using Too Much Debt?
Mar 27Is Faes Farma (BME:FAE) A Risky Investment?
Sep 21Is Faes Farma (BME:FAE) Using Too Much Debt?
May 01Recent updates
Faes Farma (BME:FAE) Is Due To Pay A Dividend Of €0.0332
Jan 06Faes Farma's (BME:FAE) Dividend Will Be €0.0332
Dec 03Faes Farma, S.A. (BME:FAE) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Nov 03Faes Farma, S.A. (BME:FAE) Just Released Its Full-Year Earnings: Here's What Analysts Think
Mar 01Faes Farma (BME:FAE) Is Due To Pay A Dividend Of €0.0316
Dec 18Faes Farma (BME:FAE) Will Pay A Dividend Of €0.0316
Dec 04Does Faes Farma (BME:FAE) Have A Healthy Balance Sheet?
Nov 24Here's Why Faes Farma (BME:FAE) Can Manage Its Debt Responsibly
May 03Is There An Opportunity With Faes Farma, S.A.'s (BME:FAE) 50% Undervaluation?
Sep 21Is Faes Farma (BME:FAE) A Risky Investment?
Aug 03Faes Farma (BME:FAE) Ticks All The Boxes When It Comes To Earnings Growth
Jun 17Is Faes Farma (BME:FAE) Using Too Much Debt?
Mar 27Faes Farma (BME:FAE) Is Increasing Its Dividend To €0.14
Dec 13Faes Farma's (BME:FAE) Dividend Will Be Increased To €0.17
Nov 29Is Faes Farma (BME:FAE) A Risky Investment?
Sep 21Faes Farma, S.A. (BME:FAE) Interim Results: Here's What Analysts Are Forecasting For This Year
Jul 31Is Faes Farma (BME:FAE) Using Too Much Debt?
May 01Estimating The Fair Value Of Faes Farma, S.A. (BME:FAE)
Apr 07Does Faes Farma, S.A. (BME:FAE) Have A Place In Your Dividend Portfolio?
Mar 22Faes Farma's (BME:FAE) Solid Earnings May Rest On Weak Foundations
Mar 06Faes Farma (BME:FAE) Has Compensated Shareholders With A Respectable 61% Return On Their Investment
Feb 22I Ran A Stock Scan For Earnings Growth And Faes Farma (BME:FAE) Passed With Ease
Jan 16Faes Farma (BME:FAE) Seems To Use Debt Rather Sparingly
Dec 08Financial Position Analysis
Short Term Liabilities: FAE's short term assets (€346.9M) exceed its short term liabilities (€126.6M).
Long Term Liabilities: FAE's short term assets (€346.9M) exceed its long term liabilities (€24.9M).
Debt to Equity History and Analysis
Debt Level: FAE has more cash than its total debt.
Reducing Debt: FAE's debt to equity ratio has increased from 3.2% to 6.9% over the past 5 years.
Debt Coverage: FAE's debt is well covered by operating cash flow (222.6%).
Interest Coverage: FAE's interest payments on its debt are well covered by EBIT (211.4x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/02 12:24 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Faes Farma, S.A. is covered by 13 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Álvaro Arístegui Echevarría | Ahorro Corporación |
| Kamla Singh | AlphaValue |
| Guilherme Sampaio | Banco BPI, S.A. |